Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells H Dumortier, S Lacotte, G Pastorin, R Marega, W Wu, D Bonifazi, ... Nano letters 6 (7), 1522-1528, 2006 | 861 | 2006 |
CXCR3, inflammation, and autoimmune diseases S Lacotte, S Brun, S Muller, H Dumortier Annals of the New York Academy of Sciences 1173 (1), 310-317, 2009 | 411 | 2009 |
Intraportal islet transplantation: the impact of the liver microenvironment V Delaune, T Berney, S Lacotte, C Toso Transplant International 30 (3), 227-238, 2017 | 108 | 2017 |
Early Differentiated CD138highMHCII+IgG+ Plasma Cells Express CXCR3 and Localize into Inflamed Kidneys of Lupus Mice S Lacotte, M Decossas, C Le Coz, S Brun, S Muller, H Dumortier PloS one 8 (3), e58140, 2013 | 78 | 2013 |
Effects of the gut–liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver LA Orci, S Lacotte, V Delaune, F Slits, G Oldani, V Lazarevic, C Rossetti, ... Journal of hepatology 68 (5), 978-985, 2018 | 71 | 2018 |
Interfacing functionalized carbon nanohorns with primary phagocytic cells S Lacotte, A García, M Décossas, WT Al‐Jamal, S Li, K Kostarelos, ... Advanced Materials 20 (12), 2421-2426, 2008 | 59 | 2008 |
Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent manner RPH Meier, J Meyer, E Montanari, S Lacotte, A Balaphas, YD Muller, ... International journal of molecular sciences 20 (6), 1295, 2019 | 57 | 2019 |
Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation LA Orci, T Berney, PE Majno, S Lacotte, G Oldani, P Morel, G Mentha, ... Journal of British Surgery 102 (10), 1250-1257, 2015 | 57 | 2015 |
Pre-retrieval reperfusion decreases cancer recurrence after rat ischemic liver graft transplantation G Oldani, LA Crowe, LA Orci, F Slits, L Rubbia-Brandt, C de Vito, P Morel, ... Journal of hepatology 61 (2), 278-285, 2014 | 41 | 2014 |
The role of hepatic ischemia–reperfusion injury and liver parenchymal quality on cancer recurrence LA Orci, S Lacotte, G Oldani, P Morel, G Mentha, C Toso Digestive diseases and sciences 59, 2058-2068, 2014 | 38 | 2014 |
An optimized method for mouse liver sinusoidal endothelial cell isolation J Meyer, S Lacotte, P Morel, C Gonelle-Gispert, L Bühler Experimental cell research 349 (2), 291-301, 2016 | 37 | 2016 |
Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW) F1 mice S Lacotte, H Dumortier, M Décossas, JP Briand, S Muller The Journal of Immunology 184 (7), 3937-3945, 2010 | 35 | 2010 |
Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma S Lacotte, F Slits, LA Orci, J Meyer, G Oldani, V Delaune, ... Oncoimmunology 5 (11), e1234565, 2016 | 34 | 2016 |
Orthotopic liver transplantation in rats G Oldani, S Lacotte, P Morel, G Mentha, C Toso JoVE (Journal of Visualized Experiments), e4143, 2012 | 34 | 2012 |
Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis LA Orci, S Lacotte, G Oldani, F Slits, C De Vito, LA Crowe, ... Journal of British Surgery 103 (4), 417-426, 2016 | 32 | 2016 |
Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response V Delaune, LA Orci, S Lacotte, A Peloso, J Schrenzel, V Lazarevic, ... Expert opinion on biological therapy 18 (10), 1061-1071, 2018 | 31 | 2018 |
Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events S Lacotte, T Berney, AMJ Shapiro, C Toso Expert opinion on biological therapy 11 (1), 55-66, 2011 | 30 | 2011 |
Xenogeneic chimera—Generated by blastocyst complementation—As a potential unlimited source of recipient‐tailored organs G Oldani, A Peloso, S Lacotte, R Meier, C Toso Xenotransplantation 24 (4), e12327, 2017 | 21 | 2017 |
Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade L Giovannoni, YD Muller, S Lacotte, G Parnaud, S Borot, RPH Meier, ... Transplantation 99 (1), 29-35, 2015 | 20 | 2015 |
Quantification of islet loss and graft functionality during immune rejection by 3-tesla MRI in a rat model S Borot, LA Crowe, G Parnaud, F Ris, R Meier, L Giovannoni, YD Müller, ... Transplantation 96 (5), 438-444, 2013 | 20 | 2013 |